SiTime Corporation vs Tilray Brands Inc — how do they compare? SiTime Corporation trades at $684 (market cap $20.05B), while Tilray Brands Inc trades at $4.81 (market cap $649.42M). The key difference: SiTime Corporation is far larger — about 30.9× Tilray Brands Inc's market cap, and SiTime Corporation is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| SITM | TLRY | |
|---|---|---|
Market Cap | $20.05B | $649.42M |
Sector | Technology | Health |
52-Week High | $901.60 | $21.00 |
52-Week Low | $212.77 | $3.88 |
Enterprise Value | $19.45B | $816.55M |
Signals from Pluang's Aura AI — not financial advice
SITM stock surged 5.5% to $725.28, showing strong momentum with three consecutive quarterly earnings beats and bullish technical indicators. The company reported 127% revenue growth in Q2 2026 and expects further acceleration from AI infrastructure demand and the Renesas acquisition. Despite negative 2025 earnings, profitability improved significantly with net income turning positive in 2026 projections.
Outlook remains positive with 100% analyst buy ratings and $870 consensus target, though premium valuations (P/E 1,148, P/S 39) and execution risks from the Renesas integration warrant caution. AI timing growth presents substantial opportunity, but stock appears fully valued after recent run-up.
No Aura AI signal available yet.
Trailing returns across standard periods
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →